ResearcherLund UniversityNo recent work listed
Chinmay Gundewar
Matched on OpenAlex author ID A5049416351. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper
Papers 4
- The role of SPARC expression in pancreatic cancer progression and patient survival. Co-author DOI 10.3109/00365521.2015.1024281↗
- Analysis of MUC4 expression in human pancreatic cancer xenografts in immunodeficient mice. Co-author PMID 25075011↗
- Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Co-author DOI 10.3109/00365521.2013.832368↗
- Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition. First author DOI 10.1016/j.pan.2012.04.005↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roland E. Andersson · 4 shared papers, 2012–2015 · strength 0.21
- Paper The role of SPARC expression in pancreatic cancer progression and patient survival. DOI 10.3109/00365521.2015.1024281↗
- Paper Analysis of MUC4 expression in human pancreatic cancer xenografts in immunodeficient mice. PMID 25075011↗
- Paper Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. DOI 10.3109/00365521.2013.832368↗
- Daniel Ansari · 3 shared papers, 2013–2015 · strength 0.17
- Paper The role of SPARC expression in pancreatic cancer progression and patient survival. DOI 10.3109/00365521.2015.1024281↗
- Paper Analysis of MUC4 expression in human pancreatic cancer xenografts in immunodeficient mice. PMID 25075011↗
- Paper Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. DOI 10.3109/00365521.2013.832368↗
- Monika Posaric Bauden · 2 shared papers, 2013–2014 · strength 0.10
- Carlos Urey · 1 shared paper, 2013 · strength 0.05
- Emelie Karnevi · 1 shared paper, 2012 · strength 0.04
- Ann H. Rosendahl · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.